Lannett Announces Launch Of FDA Approved Levothyroxine Tablets

PHILADELPHIA, Aug. 3, 2020 -- (Healthcare Sales & Marketing Network) -- Lannett Company, Inc. (NYSE: LCI) today announced the launch of Cediprof, Inc.'s FDA approved Levothyroxine Sodium Tablets USP, under the companies recently announced interim exclusiv... Biopharmaceuticals, Endocrinology, Product Launch Lannett, Levothyroxine
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news